IFD	Invasive fungal disease
IA	Invasive aspergillosis
CAPA	COVID-19-associated pulmonary aspergillosis
IAPA	Influenza-associated pulmonary aspergillosis
BDG	(1,3)-β-D-glucan
GM	Galactomannan
ODI	Optical density index
CrAg	Cryptococcal antigen
LFA/LFD	Lateral-flow assay/device
PCR	Polymerase chain reaction
mNGS	Metagenomic next-generation sequencing
BAL	Bronchoalveolar lavage
CT	Computed tomography
MRI	Magnetic resonance imaging
CSF	Cerebrospinal fluid
TDM	Therapeutic drug monitoring
HSCT	Hematopoietic stem cell transplantation
SOT	Solid organ transplantation
GVHD	Graft-versus-host disease
ICU	Intensive care unit
CVC	Central venous catheter
TPN	Total parenteral nutrition
RRT	Renal replacement therapy
DKA	Diabetic ketoacidosis
ICP	Intracranial pressure
ART	Antiretroviral therapy
NPV/PPV	Negative/positive predictive value
MIC	Minimum inhibitory concentration
PK/PD	Pharmacokinetic/pharmacodynamic
L-AmB	Liposomal amphotericin B
ABLC	Amphotericin B lipid complex
AFS	Antifungal stewardship
EORTC/MSGERC	European Organization for Research and Treatment of Cancer/Mycoses Study Group Education and Research Consortium
ECMM/ISHAM/ASM	European Confederation of Medical Mycology/International Society for Human and Animal Mycology/American Society for Microbiology
FUNDICU	Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (consensus definitions)
AspICU	Clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients
EBCS	Evidence-based clinical standard
MALDI-TOF	Matrix-assisted laser desorption/ionization time-of-flight (mass spectrometry)